Lipids + Genomics = Lipomics

Expression genomics and proteomics approaches have provided important insights into the roles of specific genes and proteins. Now, researchers monitoring other components of living organisms are finding ways to adapt the "big picture" outlook characteristic of these disciplines to their own work. For example, Lipomics Technologies Inc. of West Sacramento, Calif., is developing methods and tools to simultaneously quantify lipid metabolites on a large scale. As with other types of comprehensive an

Written byDeborah Fitzgerald
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

For example, Lipomics Technologies Inc. of West Sacramento, Calif., is developing methods and tools to simultaneously quantify lipid metabolites on a large scale. As with other types of comprehensive analyses, the data obtained in a lipid profile can be used not only to address the experimental question at hand, but can also be incorporated into databases for future in silico studies.

According to Lipomics Technologies and its collaborators at the University of California, Davis, lipids are an attractive subset of metabolites for bioinformatic studies because they are important biological mediators, and their concentrations are reflective of both diet and metabolism.1 The impact of dietary lipids and lipid metabolism on a range of conditions, including diabetes, obesity, and cardiovascular disease, underscores the importance of these metabolites to human health.

Lipomics Technologies' gas chromatography-based TrueMass™ technology enables the simultaneous quantification of over 300 lipid metabolites from a given sample, which can consist ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies